Cambridge Innovation Capital

Imagen Ltd designs and develops media archive management solutions. The company offers Imagen2, a media asset management and publishing system; ImagenCloud, a cloud based system to manage and publish videos and images; and Orbital, a compliance recording system. Its clientele include Ministry of Defence, The Police, The BBC, ITN, The Imperial War Museum, British Telecom, and British Pathe. Imagen Ltd was formerly known as Cambridge Imaging Systems Limited and changed its name to Imagen Ltd in August 2015. The company was founded in 1991 and is based in Willingham, United Kingdom.

Fluidic Analytics Limited designs, develops, and manufactures equipment for the characterization of proteins in laboratory, medical, and consumer applications. The company provides Fluidity One, a product that enables in-solution sizing and quantification of native protein. The company also offers Fluidity One-W, a product that enables high sensitivity in-solution analysis of protein size and protein interaction kinetics. Its products are used for applications, including protein quality, interactions, aggregation, and sizing. The company serves scientists, clinics, and healthcare providers. Fluidic Analytics Limited was founded in 2013 and is based in Cambridge, United Kingdom.

Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers. The company's therapeutics identify gut bacteria linked to phenotype with unprecedented precision, enabling researchers to phenotype before testing of candidate bacteria in advanced human in vitro and in vivo models.

Sense Biodetection Limited provides molecular diagnostics solutions. The company offers True Point-of-Care, a clinical diagnostic product for users that would improve treatment and enable informed decisions in a decentralized healthcare system. The company was incorporated in 2013 and is headquartered in Abingdon, United Kingdom.

Congenica Ltd. develops and operates clinical data solutions for genetic diagnosis worldwide. The company offers Sapientia, a clinical genomic analytics platform that provides integration of human DNA sequences with deep clinical phenotyping, enabling clinicians and researchers to provide actionable interpretation of genetic disease for patients. Its platform is also used for clinical diagnosis, prognosis, and research by clinicians and researchers. The company’s platform is also used in personalized medicine applications, such as creating disease registries, identifying patient populations for clinical studies, and discovering novel drug targets and biomarkers. Congenica Ltd. was incorporated in 2012 and is based in Hinxton, United Kingdom.

AudioTelligence Ltd develops a software that pre-processes the sound and solves loud background noise problem that makes it difficult to hear or understand a conversation for humans and voice activated devices. The company delivers real-time audio processing technology for the enhancement of automatic speech recognition (ASR) systems. The company's software transforms the clarity and intelligibility of the audio. The company was founded in 2017 and is based in Cambridge, United Kingdom.

Founded in 2016 with a mission to empower people in business to make better decisions, Secondmind - The Decisions Company - is underpinned by years of award-winning, practical artificial intelligence (AI) and machine learning (ML) research, performed by a team of world-class researchers, data scientists and ML engineers. Secondmind closes the gap between people and AI, and supercharges decision-making with the Secondmind Decision Engine, an intuitive and insightful software platform that helps people in industries from supply chain to automotive predict, plan, influence outcomes, manage risk, and make complex decisions with ease and confidence. Secondmind is backed by leading venture funds including Amadeus Capital, Atlantic Bridge, and Cambridge Innovation Capital, among others.

Seldon Technologies Ltd. operates an open-source machine learning deployment platform. Its Seldon Deploy, which enables data science specialists to move into production more easily with compliance, also offers audit trails and approvals along with detailed explanations. The company was founded in 2014 and is based in Shoreditch, United Kingdom.

Z Factor Limited is a drug discovery company founded in 2015 to identify and develop therapeutic agents to treat alpha-1-antitrypsin deficiency. The company was created by Index Ventures in partnership with the University of Cambridge.

Riverlane is the most advanced quantum computing software developer

AudioTelligence Ltd develops a software that pre-processes the sound and solves loud background noise problem that makes it difficult to hear or understand a conversation for humans and voice activated devices. The company delivers real-time audio processing technology for the enhancement of automatic speech recognition (ASR) systems. The company's software transforms the clarity and intelligibility of the audio. The company was founded in 2017 and is based in Cambridge, United Kingdom.

Origami Energy Ltd., a technology company, develops and commercializes a technology platform for distributed energy applications. It offers technology and solutions to connect, control, and manage a network of existing energy generating/energy using/energy storing assets connected to the electricity grid. The company was incorporated in 2013 and is based in London, United Kingdom.

Founded in 2016 with a mission to empower people in business to make better decisions, Secondmind - The Decisions Company - is underpinned by years of award-winning, practical artificial intelligence (AI) and machine learning (ML) research, performed by a team of world-class researchers, data scientists and ML engineers. Secondmind closes the gap between people and AI, and supercharges decision-making with the Secondmind Decision Engine, an intuitive and insightful software platform that helps people in industries from supply chain to automotive predict, plan, influence outcomes, manage risk, and make complex decisions with ease and confidence. Secondmind is backed by leading venture funds including Amadeus Capital, Atlantic Bridge, and Cambridge Innovation Capital, among others.

Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers. The company's therapeutics identify gut bacteria linked to phenotype with unprecedented precision, enabling researchers to phenotype before testing of candidate bacteria in advanced human in vitro and in vivo models.

Salience Labs is building a hybrid photonic-electronic chip for AI. We have designed a massively parallel, ultra-high-throughput Photonic Tensor Processing Unit. Photonics allows data to be modulated at up to 100 GHZ, and allows for high levels of parallelization using multiplexing. We integrate this photonic unit into a SoC architecture designed to exploit its high throughput for AI inference. Salience Labs technology is based on decades of research collaboration between Oxford University and the University of Münster, Germany.

Origami Energy Ltd., a technology company, develops and commercializes a technology platform for distributed energy applications. It offers technology and solutions to connect, control, and manage a network of existing energy generating/energy using/energy storing assets connected to the electricity grid. The company was incorporated in 2013 and is based in London, United Kingdom.

Undo Ltd. develops debugging tools for developers, software architects, product managers, and field application engineers. It offers live recorder that records and replay the execution of software, records the programming errors, debug the recordings, and integrates and automates container platform. The company also provides UndoDB, an interactive reversible debugger for C/C++ on Linux and Android. It serves data management, networking, electronic design automation, and financial industries. Undo Ltd. was incorporated in 2005 and is based in Cambridge, United Kingdom with an additional office location in San Francisco, California.

River Lane Research Ltd develops and offers quantum computing software that simulates engine for microscopic systems and replaces laboratory tests in areas, such as drug discovery. Its software leverages quantum computer and uses quantum computers for simulation of quantum systems. River Lane Research Ltd was incorporated in 2016 and is based in Cambridge, United Kingdom.

Congenica Ltd. develops and operates clinical data solutions for genetic diagnosis worldwide. The company offers Sapientia, a clinical genomic analytics platform that provides integration of human DNA sequences with deep clinical phenotyping, enabling clinicians and researchers to provide actionable interpretation of genetic disease for patients. Its platform is also used for clinical diagnosis, prognosis, and research by clinicians and researchers. The company’s platform is also used in personalized medicine applications, such as creating disease registries, identifying patient populations for clinical studies, and discovering novel drug targets and biomarkers. Congenica Ltd. was incorporated in 2012 and is based in Hinxton, United Kingdom.

GeoSpock Limited develops data indexing platform, which provides analytics, builds insight, and enables predictions across space and time. The company's products include GeoSpock DB Discovery and GeoSpock DB Enterprise that offers cloud-based database service for all location tagged information and enables the user to carry out dynamic data fusion and query complex data for performance analytics. It powers any location based service from real time tracking of entire logistics fleets to local taxi finding application. The company was incorporated in 2013 and is based in Cambridge, United Kingdom with additional offices in Tokyo, Japan; and Singapore.

GeoSpock Limited develops data indexing platform, which provides analytics, builds insight, and enables predictions across space and time. The company's products include GeoSpock DB Discovery and GeoSpock DB Enterprise that offers cloud-based database service for all location tagged information and enables the user to carry out dynamic data fusion and query complex data for performance analytics. It powers any location based service from real time tracking of entire logistics fleets to local taxi finding application. The company was incorporated in 2013 and is based in Cambridge, United Kingdom with additional offices in Tokyo, Japan; and Singapore.

Swim.Ai, Inc. develops advance analytics software that processes data in devices at the edge of a network. The company’s product includes SWIM EDX turns all streaming edge data into insights and predictions in real-time without the challenges of big data. It offers solutions for original equipment manufacturers, service providers, enterprises, cities, Internet of Things (IoT) vendors, and developers. It combines edge computing, machine learning, and self-training digital twins in mesh architecture. The company was founded in 2015 and is based in San Jose, California.

Storm Therapeutics Limited discovers and develops small molecule drugs that target RNA-modifying enzymes, for treatment of cancer. Storm Therapeutics Limited was formerly known as Iceni Therapeutics Limited and changed its name to Storm Therapeutics Limited in June 2016. The company was incorporated in 2015 and is based in Cambridge, United Kingdom.

Seldon Technologies Ltd. operates an open-source machine learning deployment platform. Its Seldon Deploy, which enables data science specialists to move into production more easily with compliance, also offers audit trails and approvals along with detailed explanations. The company was founded in 2014 and is based in Shoreditch, United Kingdom.

Founded in 2016 with a mission to empower people in business to make better decisions, Secondmind - The Decisions Company - is underpinned by years of award-winning, practical artificial intelligence (AI) and machine learning (ML) research, performed by a team of world-class researchers, data scientists and ML engineers. Secondmind closes the gap between people and AI, and supercharges decision-making with the Secondmind Decision Engine, an intuitive and insightful software platform that helps people in industries from supply chain to automotive predict, plan, influence outcomes, manage risk, and make complex decisions with ease and confidence. Secondmind is backed by leading venture funds including Amadeus Capital, Atlantic Bridge, and Cambridge Innovation Capital, among others.

Origami Energy Ltd., a technology company, develops and commercializes a technology platform for distributed energy applications. It offers technology and solutions to connect, control, and manage a network of existing energy generating/energy using/energy storing assets connected to the electricity grid. The company was incorporated in 2013 and is based in London, United Kingdom.

Secondmind Ltd. develops an online software platform that uses machine learning algorithms to make artificial intelligence-based decisions. Its solution includes Secondmind Decision Engine, a cloud-based intuitive software platform that enables users to predict, plan, influence outcomes, manage risk, and make complex decisions with ease. The company was incorporated in 2016 and is based in Cambridge, United Kingdom. Secondmind Ltd. was formerly known as Prowler.io Limited and changed its name to Secondmind Ltd. in October 2020. The company was founded in 2016 and is based in Cambridge, United Kingdom.

Riverlane is the most advanced quantum computing software developer

Storm Therapeutics Limited discovers and develops small molecule drugs that target RNA-modifying enzymes, for treatment of cancer. Storm Therapeutics Limited was formerly known as Iceni Therapeutics Limited and changed its name to Storm Therapeutics Limited in June 2016. The company was incorporated in 2015 and is based in Cambridge, United Kingdom.

CMR Surgical is to make minimal access surgery available to all. With Versius they have delivered a next-generation tool to fit seamlessly into today’s operating rooms, working in harmony with the surgeon to improve patient outcomes and deliver value for healthcare providers.

Congenica Ltd. develops and operates clinical data solutions for genetic diagnosis worldwide. The company offers Sapientia, a clinical genomic analytics platform that provides integration of human DNA sequences with deep clinical phenotyping, enabling clinicians and researchers to provide actionable interpretation of genetic disease for patients. Its platform is also used for clinical diagnosis, prognosis, and research by clinicians and researchers. The company’s platform is also used in personalized medicine applications, such as creating disease registries, identifying patient populations for clinical studies, and discovering novel drug targets and biomarkers. Congenica Ltd. was incorporated in 2012 and is based in Hinxton, United Kingdom.

Imagen Ltd designs and develops media archive management solutions. The company offers Imagen2, a media asset management and publishing system; ImagenCloud, a cloud based system to manage and publish videos and images; and Orbital, a compliance recording system. Its clientele include Ministry of Defence, The Police, The BBC, ITN, The Imperial War Museum, British Telecom, and British Pathe. Imagen Ltd was formerly known as Cambridge Imaging Systems Limited and changed its name to Imagen Ltd in August 2015. The company was founded in 1991 and is based in Willingham, United Kingdom.

PolyProx Therapeutics is developer of a novel class of drug intended to provide new therapies for cancer treatment. The company's drug will use novel engineered protein that is able to selectively target tumour cells and trigger natural degradation machinery within the cell, enabling cancer patients to benefit from the treatment that targets and remove disease-causing proteins.

Swim.Ai, Inc. develops advance analytics software that processes data in devices at the edge of a network. The company’s product includes SWIM EDX turns all streaming edge data into insights and predictions in real-time without the challenges of big data. It offers solutions for original equipment manufacturers, service providers, enterprises, cities, Internet of Things (IoT) vendors, and developers. It combines edge computing, machine learning, and self-training digital twins in mesh architecture. The company was founded in 2015 and is based in San Jose, California.

Inivata is a clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis to improve testing and treatment for oncologists and their patients. Unlike conventional invasive biopsies, Inivata detects and analyses genomic material from a cancer patient’s cell-free, circulating tumour DNA (ctDNA) which can be collected through a simple blood sample. This non-invasive approach – a liquid biopsy – offers a revolution in how cancer is detected, monitored and treated.

Audio Analytic is the pioneer of sound recognition and is on a mission to give all machines a sense of hearing beyond speech and music. Its embedded, cloudless AI software gives consumer technology the sense of hearing. By understanding what is happening around these products Audio Analytic provides devices and services with contextual awareness, that empower multiple applications across key values such as safety, security, wellbeing, health, entertainment, and communication. Founded in 2010, Audio Analytic is based in Cambridge, UK.

Imagen Ltd designs and develops media archive management solutions. The company offers Imagen2, a media asset management and publishing system; ImagenCloud, a cloud based system to manage and publish videos and images; and Orbital, a compliance recording system. Its clientele include Ministry of Defence, The Police, The BBC, ITN, The Imperial War Museum, British Telecom, and British Pathe. Imagen Ltd was formerly known as Cambridge Imaging Systems Limited and changed its name to Imagen Ltd in August 2015. The company was founded in 1991 and is based in Willingham, United Kingdom.

CMR Surgical is to make minimal access surgery available to all. With Versius they have delivered a next-generation tool to fit seamlessly into today’s operating rooms, working in harmony with the surgeon to improve patient outcomes and deliver value for healthcare providers.

Congenica Ltd. develops and operates clinical data solutions for genetic diagnosis worldwide. The company offers Sapientia, a clinical genomic analytics platform that provides integration of human DNA sequences with deep clinical phenotyping, enabling clinicians and researchers to provide actionable interpretation of genetic disease for patients. Its platform is also used for clinical diagnosis, prognosis, and research by clinicians and researchers. The company’s platform is also used in personalized medicine applications, such as creating disease registries, identifying patient populations for clinical studies, and discovering novel drug targets and biomarkers. Congenica Ltd. was incorporated in 2012 and is based in Hinxton, United Kingdom.

Jukedeck is developing an artificially intelligent music composer - a system that writes original music completely on its own. Jukedeck is based on state-of-the-art technology they are building that brings artificial intelligence to music composition and production. They are training deep neural networks to understand music composition at a granular level, so that they can build tools to aid creativity.

Audio Analytic is the pioneer of sound recognition and is on a mission to give all machines a sense of hearing beyond speech and music. Its embedded, cloudless AI software gives consumer technology the sense of hearing. By understanding what is happening around these products Audio Analytic provides devices and services with contextual awareness, that empower multiple applications across key values such as safety, security, wellbeing, health, entertainment, and communication. Founded in 2010, Audio Analytic is based in Cambridge, UK.

Sense Biodetection Limited provides molecular diagnostics solutions. The company offers True Point-of-Care, a clinical diagnostic product for users that would improve treatment and enable informed decisions in a decentralized healthcare system. The company was incorporated in 2013 and is headquartered in Abingdon, United Kingdom.

Inivata is a clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis to improve testing and treatment for oncologists and their patients. Unlike conventional invasive biopsies, Inivata detects and analyses genomic material from a cancer patient’s cell-free, circulating tumour DNA (ctDNA) which can be collected through a simple blood sample. This non-invasive approach – a liquid biopsy – offers a revolution in how cancer is detected, monitored and treated.

CMR Surgical is to make minimal access surgery available to all. With Versius they have delivered a next-generation tool to fit seamlessly into today’s operating rooms, working in harmony with the surgeon to improve patient outcomes and deliver value for healthcare providers.

CMR Surgical Limited designs and manufactures medical devices for minimal access surgery applications. The company designs and manufactures Versius surgical robotic systems for laparoscopic surgery for the healthcare sector. The company was formerly known as Cambridge Medical Robotics Limited and changed its name to CMR Surgical Limited in February, 2018. CMR Surgical Limited was incorporated in 2014 and is based in Cambridge, United Kingdom.

GeoSpock Limited develops data indexing platform, which provides analytics, builds insight, and enables predictions across space and time. The company's products include GeoSpock DB Discovery and GeoSpock DB Enterprise that offers cloud-based database service for all location tagged information and enables the user to carry out dynamic data fusion and query complex data for performance analytics. It powers any location based service from real time tracking of entire logistics fleets to local taxi finding application. The company was incorporated in 2013 and is based in Cambridge, United Kingdom with additional offices in Tokyo, Japan; and Singapore.

Origami Energy Ltd., a technology company, develops and commercializes a technology platform for distributed energy applications. It offers technology and solutions to connect, control, and manage a network of existing energy generating/energy using/energy storing assets connected to the electricity grid. The company was incorporated in 2013 and is based in London, United Kingdom.

Complement Therapeutics operates as a preclinical stage company. Complement Therapeutics develops a precision medicine diagnostic platform allowing it to stratify patients based on their complement-activation profile with the potential to enable both patient selection and serving as an efficacy biomarker in future clinical studies.

Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.

GeoSpock Limited develops data indexing platform, which provides analytics, builds insight, and enables predictions across space and time. The company's products include GeoSpock DB Discovery and GeoSpock DB Enterprise that offers cloud-based database service for all location tagged information and enables the user to carry out dynamic data fusion and query complex data for performance analytics. It powers any location based service from real time tracking of entire logistics fleets to local taxi finding application. The company was incorporated in 2013 and is based in Cambridge, United Kingdom with additional offices in Tokyo, Japan; and Singapore.

PragmatIC Printing Limited, trading as PragmatIC, designs and manufactures flexible integrated circuits. The company offers flexible integrated circuit building blocks supporting different functions; a process design kit for integration with an existing electronic design automation environment; proximity field communication products for capacitive energy transfer; near field communications solutions; solutions for driving displays or visual indicators; and solutions support analogue interfaces to sense environmental inputs. Its products are used in smart packaging, security features, toys and games, hybrid electronics, and other applications. The company serves customers across consumer goods, packaging, security printing, and mainstream electronics sectors. PragmatIC Printing Limited was formerly known as Nano ePrint Ltd. and changed its name to PragmatIC Printing Limited in December 2011. The company was founded in 2006 and is based in Cambridge, United Kingdom with an additional production facility in Sedgefield, United Kingdom.

Epitopea is a transatlantic biotechnology company developing transformational immunotherapies to treat cancer by targeting a new class of antigens that are broadly shared between patients with the same cancer indication. Cryptigen™ TSAs are discovered by a proprietary approach deploying immunopetidomics, mass spectrometry, genomics, and bioinformatics, which allows the identification of conserved, aberrantly-expressed, tumour-specific antigens, hidden in cancer's 'junk' DNA. These hidden Cryptigen™ TSAs have been identified by research led by Drs. Claude Perreault and Pierre Thibault at the Institute for Research in Immunology and Cancer at Université de Montréal.

CEDAR Audio is the world's only company dedicated solely to audio restoration and speech enhancement for film, post, TV and radio broadcast, CD and DVD mastering, libraries and archives, and for audio forensic investigation. Established in 1988 following five years of research funded by the British Library National Sound Archive, CEDAR Audio is based in Cambridge, UK, and retains strong academic links with Cambridge University, itself one of the world's leading centres for digital signal processing research. The company currently numbers two Cambridge University Professors and a Director of Studies among its Directors, further strengthening its ability to remain at the forefront of its field. CEDAR Audio is committed to furthering the science and technology of audio restoration and speech enhancements in all its forms. It not only manufactures many of the leading products in these fields, but actively pursues research into new techniques in each of them. The company also places a premium on the highest standards of customer support, and has earned numerous accolades in this area.

PolyProx Therapeutics is developer of a novel class of drug intended to provide new therapies for cancer treatment. The company's drug will use novel engineered protein that is able to selectively target tumour cells and trigger natural degradation machinery within the cell, enabling cancer patients to benefit from the treatment that targets and remove disease-causing proteins.

CMR Surgical is to make minimal access surgery available to all. With Versius they have delivered a next-generation tool to fit seamlessly into today’s operating rooms, working in harmony with the surgeon to improve patient outcomes and deliver value for healthcare providers.

Undo Ltd. develops debugging tools for developers, software architects, product managers, and field application engineers. It offers live recorder that records and replay the execution of software, records the programming errors, debug the recordings, and integrates and automates container platform. The company also provides UndoDB, an interactive reversible debugger for C/C++ on Linux and Android. It serves data management, networking, electronic design automation, and financial industries. Undo Ltd. was incorporated in 2005 and is based in Cambridge, United Kingdom with an additional office location in San Francisco, California.

Storm Therapeutics Limited discovers and develops small molecule drugs that target RNA-modifying enzymes, for treatment of cancer. Storm Therapeutics Limited was formerly known as Iceni Therapeutics Limited and changed its name to Storm Therapeutics Limited in June 2016. The company was incorporated in 2015 and is based in Cambridge, United Kingdom.

Origami Energy Ltd., a technology company, develops and commercializes a technology platform for distributed energy applications. It offers technology and solutions to connect, control, and manage a network of existing energy generating/energy using/energy storing assets connected to the electricity grid. The company was incorporated in 2013 and is based in London, United Kingdom.

Inivata is a clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis to improve testing and treatment for oncologists and their patients. Unlike conventional invasive biopsies, Inivata detects and analyses genomic material from a cancer patient’s cell-free, circulating tumour DNA (ctDNA) which can be collected through a simple blood sample. This non-invasive approach – a liquid biopsy – offers a revolution in how cancer is detected, monitored and treated.

Congenica Ltd. develops and operates clinical data solutions for genetic diagnosis worldwide. The company offers Sapientia, a clinical genomic analytics platform that provides integration of human DNA sequences with deep clinical phenotyping, enabling clinicians and researchers to provide actionable interpretation of genetic disease for patients. Its platform is also used for clinical diagnosis, prognosis, and research by clinicians and researchers. The company’s platform is also used in personalized medicine applications, such as creating disease registries, identifying patient populations for clinical studies, and discovering novel drug targets and biomarkers. Congenica Ltd. was incorporated in 2012 and is based in Hinxton, United Kingdom.

PervasID is developing a high reliability, wide area passive RFID system with the potential to provide location capability based on the EPC Class1 Gen2 standard. Spun out from research activity in the Engineering Department at the University of Cambridge, the technology is now successfully deployed in several field trials.

Morphogen-IX Limited operates as a biotechnology company developing treatment for pulmonary arterial hypertension (PAH). The company was incorporated in 2015 and is headquartered in Cambridge, United Kingdom.

Morphogen-IX Limited operates as a biotechnology company developing treatment for pulmonary arterial hypertension (PAH). The company was incorporated in 2015 and is headquartered in Cambridge, United Kingdom.

Jukedeck is developing an artificially intelligent music composer - a system that writes original music completely on its own. Jukedeck is based on state-of-the-art technology they are building that brings artificial intelligence to music composition and production. They are training deep neural networks to understand music composition at a granular level, so that they can build tools to aid creativity.

Undo Ltd. develops debugging tools for developers, software architects, product managers, and field application engineers. It offers live recorder that records and replay the execution of software, records the programming errors, debug the recordings, and integrates and automates container platform. The company also provides UndoDB, an interactive reversible debugger for C/C++ on Linux and Android. It serves data management, networking, electronic design automation, and financial industries. Undo Ltd. was incorporated in 2005 and is based in Cambridge, United Kingdom with an additional office location in San Francisco, California.

Cytora transforms underwriting for commercial insurance. The Cytora Risk Engine uses artificial intelligence to learn the patterns of risks over time, enabling insurers to underwrite more efficiently and deliver fairer prices to customers. The company's goal is to raise the insurance industry to a new standard where insurance is fast and built on a foundation of tractable data. The company's products allow insurers to enhance underwriting profitability. Cytora was founded on 2014 and is headquartered in London.

Pretzel was founded by some of the world’s foremost academics in mitochondrial biology, and we benefit from the leadership of accomplished experts in drug discovery, drug development, and company formation. Our name is inspired by the focal point of our science, the mitochondrion, whose highly folded inner membrane is one of many fascinating features that make it unlike any other organelle in the body.

PragmatIC Printing Limited, trading as PragmatIC, designs and manufactures flexible integrated circuits. The company offers flexible integrated circuit building blocks supporting different functions; a process design kit for integration with an existing electronic design automation environment; proximity field communication products for capacitive energy transfer; near field communications solutions; solutions for driving displays or visual indicators; and solutions support analogue interfaces to sense environmental inputs. Its products are used in smart packaging, security features, toys and games, hybrid electronics, and other applications. The company serves customers across consumer goods, packaging, security printing, and mainstream electronics sectors. PragmatIC Printing Limited was formerly known as Nano ePrint Ltd. and changed its name to PragmatIC Printing Limited in December 2011. The company was founded in 2006 and is based in Cambridge, United Kingdom with an additional production facility in Sedgefield, United Kingdom.

Imagen Ltd designs and develops media archive management solutions. The company offers Imagen2, a media asset management and publishing system; ImagenCloud, a cloud based system to manage and publish videos and images; and Orbital, a compliance recording system. Its clientele include Ministry of Defence, The Police, The BBC, ITN, The Imperial War Museum, British Telecom, and British Pathe. Imagen Ltd was formerly known as Cambridge Imaging Systems Limited and changed its name to Imagen Ltd in August 2015. The company was founded in 1991 and is based in Willingham, United Kingdom.

GeoSpock Limited develops data indexing platform, which provides analytics, builds insight, and enables predictions across space and time. The company's products include GeoSpock DB Discovery and GeoSpock DB Enterprise that offers cloud-based database service for all location tagged information and enables the user to carry out dynamic data fusion and query complex data for performance analytics. It powers any location based service from real time tracking of entire logistics fleets to local taxi finding application. The company was incorporated in 2013 and is based in Cambridge, United Kingdom with additional offices in Tokyo, Japan; and Singapore.

Exvastat is an innovative, preclinical-stage pharmaceutical company founded in 2016. The company is developing a treatment for acute respiratory distress syndrome (ARDS) based on a repurposed drug which is marketed worldwide for other indications. The new treatment has the potential to significantly reduce the high mortality and incapacitating morbidities caused by ARDS, as well as the costs of caring for these critically ill patients to health service providers.

Storm Therapeutics Limited discovers and develops small molecule drugs that target RNA-modifying enzymes, for treatment of cancer. Storm Therapeutics Limited was formerly known as Iceni Therapeutics Limited and changed its name to Storm Therapeutics Limited in June 2016. The company was incorporated in 2015 and is based in Cambridge, United Kingdom.

AudioTelligence Ltd develops a software that pre-processes the sound and solves loud background noise problem that makes it difficult to hear or understand a conversation for humans and voice activated devices. The company delivers real-time audio processing technology for the enhancement of automatic speech recognition (ASR) systems. The company's software transforms the clarity and intelligibility of the audio. The company was founded in 2017 and is based in Cambridge, United Kingdom.

Gyroscope is an ophthalmology company developing gene therapies for the treatment of eye diseases linked to an unbalanced complement system. Gyroscope was founded to explore the convergence of advancements made in the understanding of the complement system’s impact on eye disease, the genetic basis of Age-related Macular Degeneration (AMD) and gene therapy as a mode of treatment delivery.

Sense Biodetection Limited provides molecular diagnostics solutions. The company offers True Point-of-Care, a clinical diagnostic product for users that would improve treatment and enable informed decisions in a decentralized healthcare system. The company was incorporated in 2013 and is headquartered in Abingdon, United Kingdom.

Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated. The company's therapeutics target molecular pathways that drive the most aggressive and resistant forms of cancer using innovative mechanisms, enabling cancer patients to get their predictive biomarkers detected and get their treatments started from early stage.

PetMedix is a development stage veterinary biopharmaceutical company based in Cambridge, UK. they are using the highest quality science to make the therapies their pets need and deserve, keeping them healthier, happier, and for longer. Building on more than thirty years of world-leading innovation and human drug development, they are applying the cutting edge of science to bring breakthroughs for the animals they love and care for.

Cytora Limited develops data analytics solutions for the insurance industry. The company transforms web data points into a quantified view of commercial risk that enables insurers to enter new lines without loss history and write business in existing lines through risk differentiation. Cytora Limited was incorporated in 2012 and is based in London, United Kingdom.

CMR Surgical is to make minimal access surgery available to all. With Versius they have delivered a next-generation tool to fit seamlessly into today’s operating rooms, working in harmony with the surgeon to improve patient outcomes and deliver value for healthcare providers.

CMR Surgical Limited designs and manufactures medical devices for minimal access surgery applications. The company designs and manufactures Versius surgical robotic systems for laparoscopic surgery for the healthcare sector. The company was formerly known as Cambridge Medical Robotics Limited and changed its name to CMR Surgical Limited in February, 2018. CMR Surgical Limited was incorporated in 2014 and is based in Cambridge, United Kingdom.

Congenica Ltd. develops and operates clinical data solutions for genetic diagnosis worldwide. The company offers Sapientia, a clinical genomic analytics platform that provides integration of human DNA sequences with deep clinical phenotyping, enabling clinicians and researchers to provide actionable interpretation of genetic disease for patients. Its platform is also used for clinical diagnosis, prognosis, and research by clinicians and researchers. The company’s platform is also used in personalized medicine applications, such as creating disease registries, identifying patient populations for clinical studies, and discovering novel drug targets and biomarkers. Congenica Ltd. was incorporated in 2012 and is based in Hinxton, United Kingdom.

PragmatIC Printing Limited, trading as PragmatIC, designs and manufactures flexible integrated circuits. The company offers flexible integrated circuit building blocks supporting different functions; a process design kit for integration with an existing electronic design automation environment; proximity field communication products for capacitive energy transfer; near field communications solutions; solutions for driving displays or visual indicators; and solutions support analogue interfaces to sense environmental inputs. Its products are used in smart packaging, security features, toys and games, hybrid electronics, and other applications. The company serves customers across consumer goods, packaging, security printing, and mainstream electronics sectors. PragmatIC Printing Limited was formerly known as Nano ePrint Ltd. and changed its name to PragmatIC Printing Limited in December 2011. The company was founded in 2006 and is based in Cambridge, United Kingdom with an additional production facility in Sedgefield, United Kingdom.

PetMedix is a development stage veterinary biopharmaceutical company based in Cambridge, UK. they are using the highest quality science to make the therapies their pets need and deserve, keeping them healthier, happier, and for longer. Building on more than thirty years of world-leading innovation and human drug development, they are applying the cutting edge of science to bring breakthroughs for the animals they love and care for.

Gyroscope is an ophthalmology company developing gene therapies for the treatment of eye diseases linked to an unbalanced complement system. Gyroscope was founded to explore the convergence of advancements made in the understanding of the complement system’s impact on eye disease, the genetic basis of Age-related Macular Degeneration (AMD) and gene therapy as a mode of treatment delivery.

Morphogen-IX Limited operates as a biotechnology company developing treatment for pulmonary arterial hypertension (PAH). The company was incorporated in 2015 and is headquartered in Cambridge, United Kingdom.

PervasID is developing a high reliability, wide area passive RFID system with the potential to provide location capability based on the EPC Class1 Gen2 standard. Spun out from research activity in the Engineering Department at the University of Cambridge, the technology is now successfully deployed in several field trials.

PredictImmune is developing pioneering tools for guiding treatment options in immune-mediated inflammatory diseases with the first product addressing Inflammatory Bowel Disease (both Crohn’s and ulcerative colitis). Based on world-leading research at Cambridge University, UK, they are developing a simple lab test, using a small blood sample, which accurately identifies patients at diagnosis who are at risk of experiencing severe, relapsing disease. These patients are likely to benefit from early biologics therapy. Physicians, patients and payors all recognise the value of such an approach to the management of Inflammatory Bowel Disease.

Abcodia Ltd. engages in the discovery and validation of molecular biomarkers for disease diagnosis and screening. It offers Roca Test solutions for early ovarian cancer detection to customers in Arizona, Illinois, Massachusetts, New Jersey, Texas, Georgia, Michigan, Missouri, North Carolina, Nevada, Ohio, Oregon, Virginia, Washington, Wisconsin, the District of Columbia, and the United Kingdom. The company was incorporated in 2010 and is based in London, United Kingdom.

Pretzel was founded by some of the world’s foremost academics in mitochondrial biology, and we benefit from the leadership of accomplished experts in drug discovery, drug development, and company formation. Our name is inspired by the focal point of our science, the mitochondrion, whose highly folded inner membrane is one of many fascinating features that make it unlike any other organelle in the body.

Audio Analytic is the pioneer of sound recognition and is on a mission to give all machines a sense of hearing beyond speech and music. Its embedded, cloudless AI software gives consumer technology the sense of hearing. By understanding what is happening around these products Audio Analytic provides devices and services with contextual awareness, that empower multiple applications across key values such as safety, security, wellbeing, health, entertainment, and communication. Founded in 2010, Audio Analytic is based in Cambridge, UK.

PredictImmune is developing pioneering tools for guiding treatment options in immune-mediated inflammatory diseases with the first product addressing Inflammatory Bowel Disease (both Crohn’s and ulcerative colitis). Based on world-leading research at Cambridge University, UK, they are developing a simple lab test, using a small blood sample, which accurately identifies patients at diagnosis who are at risk of experiencing severe, relapsing disease. These patients are likely to benefit from early biologics therapy. Physicians, patients and payors all recognise the value of such an approach to the management of Inflammatory Bowel Disease.

Undo Ltd. develops debugging tools for developers, software architects, product managers, and field application engineers. It offers live recorder that records and replay the execution of software, records the programming errors, debug the recordings, and integrates and automates container platform. The company also provides UndoDB, an interactive reversible debugger for C/C++ on Linux and Android. It serves data management, networking, electronic design automation, and financial industries. Undo Ltd. was incorporated in 2005 and is based in Cambridge, United Kingdom with an additional office location in San Francisco, California.

Imagen Ltd designs and develops media archive management solutions. The company offers Imagen2, a media asset management and publishing system; ImagenCloud, a cloud based system to manage and publish videos and images; and Orbital, a compliance recording system. Its clientele include Ministry of Defence, The Police, The BBC, ITN, The Imperial War Museum, British Telecom, and British Pathe. Imagen Ltd was formerly known as Cambridge Imaging Systems Limited and changed its name to Imagen Ltd in August 2015. The company was founded in 1991 and is based in Willingham, United Kingdom.

AudioTelligence Ltd develops a software that pre-processes the sound and solves loud background noise problem that makes it difficult to hear or understand a conversation for humans and voice activated devices. The company delivers real-time audio processing technology for the enhancement of automatic speech recognition (ASR) systems. The company's software transforms the clarity and intelligibility of the audio. The company was founded in 2017 and is based in Cambridge, United Kingdom.

Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.

Cytora transforms underwriting for commercial insurance. The Cytora Risk Engine uses artificial intelligence to learn the patterns of risks over time, enabling insurers to underwrite more efficiently and deliver fairer prices to customers. The company's goal is to raise the insurance industry to a new standard where insurance is fast and built on a foundation of tractable data. The company's products allow insurers to enhance underwriting profitability. Cytora was founded on 2014 and is headquartered in London.

Inivata is a clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis to improve testing and treatment for oncologists and their patients. Unlike conventional invasive biopsies, Inivata detects and analyses genomic material from a cancer patient’s cell-free, circulating tumour DNA (ctDNA) which can be collected through a simple blood sample. This non-invasive approach – a liquid biopsy – offers a revolution in how cancer is detected, monitored and treated.

Gyroscope is an ophthalmology company developing gene therapies for the treatment of eye diseases linked to an unbalanced complement system. Gyroscope was founded to explore the convergence of advancements made in the understanding of the complement system’s impact on eye disease, the genetic basis of Age-related Macular Degeneration (AMD) and gene therapy as a mode of treatment delivery.

PragmatIC Printing Limited, trading as PragmatIC, designs and manufactures flexible integrated circuits. The company offers flexible integrated circuit building blocks supporting different functions; a process design kit for integration with an existing electronic design automation environment; proximity field communication products for capacitive energy transfer; near field communications solutions; solutions for driving displays or visual indicators; and solutions support analogue interfaces to sense environmental inputs. Its products are used in smart packaging, security features, toys and games, hybrid electronics, and other applications. The company serves customers across consumer goods, packaging, security printing, and mainstream electronics sectors. PragmatIC Printing Limited was formerly known as Nano ePrint Ltd. and changed its name to PragmatIC Printing Limited in December 2011. The company was founded in 2006 and is based in Cambridge, United Kingdom with an additional production facility in Sedgefield, United Kingdom.

GeoSpock Limited develops data indexing platform, which provides analytics, builds insight, and enables predictions across space and time. The company's products include GeoSpock DB Discovery and GeoSpock DB Enterprise that offers cloud-based database service for all location tagged information and enables the user to carry out dynamic data fusion and query complex data for performance analytics. It powers any location based service from real time tracking of entire logistics fleets to local taxi finding application. The company was incorporated in 2013 and is based in Cambridge, United Kingdom with additional offices in Tokyo, Japan; and Singapore.